Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
47641
-
47642
Descriptive statistics.
Published 2024“…A sample of 147 Canadian adult participants who had attempted to decrease or quit cannabis were recruited from the community (<i>n</i> = 84, 57.14%) and crowdsourcing (<i>n =</i> 63, 42.86%). …”
-
47643
Sugar-Based Gemini Surfactants with Peptide BondsSynthesis, Adsorption, Micellization, and Biodegradability
Published 2005“…The adsorption and micellization properties of C<i><sub>n</sub></i>peLac and 2C<i><sub>n</sub></i>peLac were characterized by the measurement of their equilibrium and dynamic surface tension, steady-state fluorescence using pyrene as a probe, dynamic light scattering (DLS), and time-resolved fluorescence quenching (TRFQ), and their biodegradability was also investigated. …”
-
47644
-
47645
XTH43-RNAi impairs <i>H</i>. <i>glycines</i> parasitism, revealed by the female index (FI).
Published 2021“…<p><b>A</b>. <i>G</i>. <i>max</i> plant (left panel) prior to genetic engineering. …”
-
47646
Data_Sheet_1_A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis...
Published 2022“…Mean age was 50.2 ± 14.2 years; 64% were female. Disease activity decreased from baseline to month 24 (RA: CDAI −24.3 ± 13.5; axSpA: BASDAI −4.4 ± 2.1, and PsA: CDAI −21.7 ± 8.5, p < 0.0001, each). …”
-
47647
Data_Sheet_2_A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis...
Published 2022“…Mean age was 50.2 ± 14.2 years; 64% were female. Disease activity decreased from baseline to month 24 (RA: CDAI −24.3 ± 13.5; axSpA: BASDAI −4.4 ± 2.1, and PsA: CDAI −21.7 ± 8.5, p < 0.0001, each). …”
-
47648
Variations of the ratio of rework and regular production rates (<i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub>) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub> decreases below a turning point 0.5, the expected system cost begins to increase significantly
Published 2016“…<p>Variations of the ratio of rework and regular production rates (<i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub>) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub> decreases below a turning point 0.5, the expected system cost begins to increase significantly</p>…”
-
47649
Contribution of the through-mask leakages from the cavity and channel network distributed along the periphery of the mask; a–c and d–f are decreasing porosity <i>c</i><sub><i>k</i></sub> = 100,500,1000 (<i>kg</i>/<i>m</i><sup>2</sup> <i>s</i>) for outward protection (with nose clips) and inward protection model, respectively; the <i>k</i><sub><i>L</i></sub> for inward protection model is 0.5.
Published 2025“…<p>Contribution of the through-mask leakages from the cavity and channel network distributed along the periphery of the mask; a–c and d–f are decreasing porosity <i>c</i><sub><i>k</i></sub> = 100,500,1000 (<i>kg</i>/<i>m</i><sup>2</sup> <i>s</i>) for outward protection (with nose clips) and inward protection model, respectively; the <i>k</i><sub><i>L</i></sub> for inward protection model is 0.5.…”
-
47650
-
47651
-
47652
DataSheet_1_Multi-b-values-fitting readout-segmentation of long variable echo-trains diffusion-weighted imaging (RESOLVE DWI) in evaluation of disease activity and curative effect...
Published 2023“…Background<p>Disease activity is relevant to the treatment and prognosis of axSpA, and methods to quantitatively assess disease activity and efficacy of axSpA are still being explored.…”
-
47653
-
47654
-
47655
-
47656
-
47657
-
47658
-
47659
-
47660